Alejandro Garcia
@alej_garciamd
MD, MSc, Medical Oncologist. Gastrointestinal and Endocrine malignancies. Vall d'Hebron University Hospital. Vall d'Hebron Institute of Oncology (VHIO).
ID: 879559772
14-10-2012 07:23:34
124 Tweet
862 Followers
533 Following
Hoy tenemos una cita con los Tumores Neuroendocrinos en Barcelona! Pero si no puedes estar, también hay modalidad online. Las últimas novedades clínicas y trasacionales del último congreso de la ENETS aquí! 👇👇👇👇👇👇👇 Grupo GETNE Jaume Capdevila J Hernando @adacap_news
SEOM-GETNE clinical guidelines for the diagnosis and treatment of gastroenteropancreatic and bronchial neuroendocrine neoplasms (NENs) (2022) | SpringerLink Grupo GETNE SEOM Vall d’Hebron Institute of Oncology (VHIO) Vall d'Hebron link.springer.com/article/10.100…
3rd day #WCGIC2023 🤩🤩 …. Amazing presentations!!!! 🔝🔝 ✅Poster day: Clinicopathological and molecular features of two rara entities: Appendiceal Carcinoma and Small Bowel ADK Many thanks to the authors Sergio Bueno Alejandro Garcia J Hernando Jaume Capdevila #ResisOncoVH Vall d’Hebron Institute of Oncology (VHIO)
Join us EMBL Barcelona! We a looking for a new Head of Administration. We are seeking a brilliant operational mind to partner with brilliant science. Closing date: 13 September please reach out if you have questions. embl.org/jobs/position/… RT appreciated
It is important to have representation of all tumours in pan-cancer biomarker studies. Rare tumours are included (e.g. ACC), but what about neuroendocrine tumours? #LetsTalkAboutNETs Grupo GETNE NET- ESPAÑA NET CONNECT NANETS
Felicidades Nadia Saoudi González! Más que merecido. Feliz de ver tus éxitos hechos realidad. Te echaremos de menos...😞
Thank you very much Jaume Capdevila for your confidence and support. You are a reference and mentor for me. Without you and J Hernando all this would not be possible. My successes are also yours!
An honour to present the data from the DUTHY trial at the European Society of Neuroendocrine Tumours #ENETS24. 🥇The first data to date on the efficacy of immunotherapy in medullary thyroid carcinoma. Grupo GETNE 👇👇👇👇
🚨 A new study looking at TKI+IO in NETs. Results similar to the Grupo GETNE CABATEN study (ORR 0% in Lung NETs and 16.7% in GI-NETs although G1 and G2). It seems that the combination is not better than TKI in monotherapy. What are your impressions❓🤔
Ready for Grupo GETNE stars at #ASCO24 ⁉️ Alejandro Garcia presents the LEVEL study design and accrual. First trial evaluating the role of 177Lu-edotreotide vs Everolimus in lung & thymic WD-NET. NET- ESPAÑA ITM Isotope Technologies Munich SE
Starting the morning with the NETs session! Always a luxury to learn from the best! Jaume Capdevila Prof Chrissie Thirlwell #ESMO2024 #NETs
Another challenging day ahead in #ESMO24! Today we start today with thyroid cancer with the best hosts Laura Locati and Marcia Brose! Grupo GETNE AECAT
